There is an extended interview with John Martin on Praoactive Investors released yesterday on the back of the full year results.
The licensee issue is discussed in some detail, and John is quite positive about the level of interest from a number of companies, and the priority that is being given in the RGS/AGC JV in getting a pharma partner...i.e. it is the next major milestone they are working towards..and moving into terms sheets, etc.
He has a "high degree of confidence" a pharma partner will be appointed.
http://www.*.com.au/companies/stock...ecures-critical-japan-collaboration-7982.html
